| A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis TE King Jr, WZ Bradford, S Castro-Bernardini, EA Fagan, I Glaspole, ... New England journal of medicine 370 (22), 2083-2092, 2014 | 3848 | 2014 |
| Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials PW Noble, C Albera, WZ Bradford, U Costabel, MK Glassberg, ... The Lancet 377 (9779), 1760-1769, 2011 | 2303 | 2011 |
| Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM) EA Goncharova, DA Goncharov, A Eszterhas, DS Hunter, MK Glassberg, ... Journal of Biological Chemistry 277 (34), 30958-30967, 2002 | 512 | 2002 |
| Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials PW Noble, C Albera, WZ Bradford, U Costabel, RM Du Bois, EA Fagan, ... European Respiratory Journal 47 (1), 243-253, 2016 | 488 | 2016 |
| Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised … AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ... The lancet Respiratory medicine 8 (5), 453-460, 2020 | 451 | 2020 |
| Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial G Lanzoni, E Linetsky, D Correa, S Messinger Cayetano, RA Alvarez, ... Stem cells translational medicine 10 (5), 660-673, 2021 | 347 | 2021 |
| Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis SD Nathan, C Albera, WZ Bradford, U Costabel, I Glaspole, MK Glassberg, ... The Lancet Respiratory Medicine 5 (1), 33-41, 2017 | 319 | 2017 |
| Exploring animal models that resemble idiopathic pulmonary fibrosis J Tashiro, GA Rubio, AH Limper, K Williams, SJ Elliot, I Ninou, V Aidinis, ... Frontiers in medicine 4, 118, 2017 | 292 | 2017 |
| Allogeneic human mesenchymal stem cells in patients with idiopathic pulmonary fibrosis via intravenous delivery (AETHER): a phase I safety clinical trial MK Glassberg, J Minkiewicz, RL Toonkel, ES Simonet, GA Rubio, ... Chest 151 (5), 971-981, 2017 | 236 | 2017 |
| Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with … SD Nathan, C Albera, WZ Bradford, U Costabel, RM Du Bois, EA Fagan, ... Thorax 71 (5), 429-435, 2016 | 198 | 2016 |
| Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function C Albera, U Costabel, EA Fagan, MK Glassberg, E Gorina, L Lancaster, ... European Respiratory Journal 48 (3), 843-851, 2016 | 190 | 2016 |
| Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing RL Toonkel, JM Hare, MA Matthay, MK Glassberg American journal of respiratory and critical care medicine 188 (2), 133-140, 2013 | 165 | 2013 |
| Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials L Lancaster, C Albera, WZ Bradford, U Costabel, RM Du Bois, EA Fagan, ... BMJ open respiratory research 3 (1), e000105, 2016 | 131 | 2016 |
| Endothelin-1 promotes mitogenesis in airway smooth muscle cells. MK Glassberg, A Ergul, A Wanner, D Puett American journal of respiratory cell and molecular biology 10 (3), 316-321, 1994 | 130 | 1994 |
| A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease TJ Doyle, JS Lee, PF Dellaripa, JA Lederer, EL Matteson, A Fischer, ... Chest 145 (3), 454-463, 2014 | 107 | 2014 |
| Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis RM Jackson, MK Glassberg, CF Ramos, PA Bejarano, G Butrous, ... Lung 188, 115-123, 2010 | 99 | 2010 |
| Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase-induced cell invasiveness MK Glassberg, SJ Elliot, J Fritz, P Catanuto, M Potier, R Donahue, ... The Journal of Clinical Endocrinology & Metabolism 93 (5), 1625-1633, 2008 | 94 | 2008 |
| Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled … JJ Solomon, SK Danoff, FA Woodhead, S Hurwitz, R Maurer, I Glaspole, ... The Lancet Respiratory Medicine 11 (1), 87-96, 2023 | 90 | 2023 |
| Mesenchymal stem cells for the treatment of idiopathic pulmonary fibrosis A Tzouvelekis, R Toonkel, T Karampitsakos, K Medapalli, I Ninou, ... Frontiers in Medicine 5, 142, 2018 | 87 | 2018 |
| Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis J Tashiro, SJ Elliot, DJ Gerth, X Xia, S Pereira-Simon, R Choi, P Catanuto, ... Translational Research 166 (6), 554-567, 2015 | 86 | 2015 |
